Ingrid Skop

Ingrid Skop is an American obstetrics and gynecology physician and anti-abortion activist who is the vice president and director of medical affairs at the Charlotte Lozier Institute, the research arm of the political advocacy group Susan B. Anthony Pro-Life America. The Texas Tribune has called Skop "the first call for anyone looking for an OB/GYN to publicly defend abortion restrictions".

Life Skop earned a Bachelor of Science in physiology from the Oklahoma State University–Stillwater. She received a M.D. at the Washington University School of Medicine.

Skop is a member of the American Association of Pro-Life Obstetricians and Gynecologists. She is the vice president and director of medical affairs at the Charlotte Lozier Institute, the research arm of the political advocacy group Susan B. Anthony Pro-Life America.

Skop is also a plaintiff in a US Supreme Court lawsuit seeking to revoke the Food and Drug Administration's approval of the abortion drug mifepristone. , the case remains under consideration with the court. The ACLU further catalogued the controversies associated with Skop's testimony across several cases. She admitted that she cited the website abort73.com for statistics in an expert report because she could not find any other data source, and that she did so despite not knowing “who created the website” nor "who supplies the numbers.” Skop also professed to not know whether “identical republication of material from another author without attribution is consistent with standards of academic integrity.” She claimed she "didn’t realize that, you know, using wording from a paper that you agreed with qualified as plagiarism." Furthermore, a number of authors and peer-reviewers of thoe articles were associated with pro-life organizations ― conflicts of interest that they did not disclose to the publisher prior to publication. Skop replaced lay advocate Nakeenya Wilson. That change was made possible following a 2023 legislative change, which replaced a single "advocate" with "community members with experience in a relevant health care field, including a field involving the analysis of health care data". Despite the fact that her position was initially intended to run until 2027, Wilson was replaced by Skop and Dr. Meenakshi Awasthi of Houston.